United States: June and Mid-Year 2013 IPO Market Review

The IPO market in June continued to produce a flow of new offerings at a torrid pace compared to recent years. The month ended with 19 IPOs—more than six times the paltry total of three in June 2012, when the IPO market was taking an early summer hiatus—and the highest June figure since the 19 in June 2005. The last week of June alone produced 10 offerings—the largest weekly total since the 11 IPOs in the first week of November 2007.

Gross proceeds of $3.64 billion in June failed to match the prior month's total of $4.56 billion but still represented the highest June figure since the $6.22 billion in June 2007. June's gross proceeds were buoyed by Coty's $1.0 billion IPO and HD Supply's $957 million IPO.

In total, the 70 IPOs in the first half of 2013 were six IPOs (9%) above the 64 in the first half of 2012 but 26% below the 95 in the first half of 2007—the recent high point of the IPO market, when the year ended with 193 IPOs. Gross proceeds for the first half of 2013 were $16.86 billion.

Year-to-date, 74% of all IPOs have been by emerging growth companies under the JOBS Act.

The average 2013 IPO has enjoyed a 17% first-day gain from its offering price—just eclipsing the 16% average first-day gain for full-year 2012. So far in 2013, 15 companies—21% of the total—have produced a first-day gain of at least 30%. An equal percentage of the year's IPOs have been "broken" (IPOs whose stock closes below the offering price on their opening day), compared to 20% in all of 2012 but still the second lowest level since 2007.

At June month-end, 42% of the year's IPOs were trading 25% or more above their offering price, including 23% up more than 50% from their offering price.

Through the first six months of 2013, the median deal size of $98.7 million is 5% higher than the $94.3 million in 2012. The median deal size of VC-backed companies is $78.8 million—the lowest level since the $72.0 million in 2007—while median deal size for non-VC backed companies is $230.0 million—58% higher than the prior ten-year average of $146.0 million. The median deal size for emerging growth companies, at $78.4 million, is less than a fifth of the $436.3 million median deal size for other companies.

The median annual revenue of IPO companies has decreased 33% from $133.6 million in 2012 to $90.1 million in 2013 to date—the lowest level since the $74.5 million in 2007. Emerging growth companies had median annual revenue of $53.5 million compared to $2.54 billion for other companies.

The percentage of profitable companies going public declined from 55% in 2012 to 44% in 2013 to date—the lowest level since the 26% in both 1999 and 2000. Only 30% of this year's life sciences and technology related IPO companies were profitable.

June IPO activity consisted of offerings by the following companies listed in the order they came to market:

  • RCS Capital, which is engaged in wholesale broker-dealer, investment banking and capital markets business activities, priced a downsized IPO at the midpoint of the range, and ended its first day of trading down 3%.
  • LightInTheBox, a Chinese global online retail company, priced at the midpoint of the range and appreciated 22% in first-day trading.
  • Textura, which provides on-demand project management software for the commercial construction industry, priced a twice upsized IPO at the high end of the range and ended its first trading day 39% above its offering price.
  • Data traffic management software maker Gigamon priced at the middle of the range and enjoyed a first-day gain of 50%.
  • Coty, a global fragrance and cosmetics conglomerate—the largest US-listed IPO in history for a consumer-products company, according to Dealogic—priced in the middle of the range and declined 1% on its first day of trading.
  • bluebird bio, a clinical-stage biotechnology company developing gene therapies for severe genetic and orphan diseases, priced an IPO upsized by just under 20% above the range and ended its first day of trading up 58%—the best first-day gain for any biotech company IPO since mid-2000.
  • PTC Therapeutics, a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post transcriptional control processes, priced an IPO upsized by 21% within the range and saw a first-day gain of 10%.
  • Truett-Hurst, a wine sales, marketing and production company, priced an IPO through W.R. Hambrecht's OpenIPO auction-based process, and ended its first day of trading down 5%.
  • In-flight wireless connectivity provider Gogo priced at the top end of the range and ended its first day of trading down 6%.
  • Esperion Therapeutics, a biopharmaceutical company focused on the treatment for elevated levels of low-density lipoprotein cholesterol, priced an upsized IPO at the middle of the range and saw a first-day gain of 4%.
  • Luxoft, a global provider of software development services and IT solutions, priced at the midpoint of the range and appreciated 20% in first day trading.
  • NanoString Technologies, which develops, manufactures and sells diagnostic systems for the analysis of genomic information, priced below the range and declined 19% on its first day of trading.
  • Aratana Therapeutics, a development-stage biopharmaceutical company focused on pet therapeutics, priced a twice upsized IPO in line with a downwardly revised price and ended its first day of trading up 38%.
  • Private equity–backed CDW, a Fortune 500 provider of integrated information technology solutions, priced a downsized IPO at the low end of a downwardly revised range and increased 8% on its first day of trading.
  • HD Supply Holdings, one of the largest industrial and construction supplies distributors in North America, priced at the low end of the reduced range and ended its first day of trading up 4%.
  • Silvercrest Asset Management, a wealth management firm, priced below the range and saw a first-day gain of 8%.
  • Tremor Video, a provider of technology-driven video advertising solutions, continued the string of companies pricing below their original range and ended its first day of trading down 15%.
  • Noodles, a fast-casual restaurant operator, priced above an upwardly revised range and enjoyed a first-day gain of 104%.
  • The Netherlands-based Prosensa Holding, a biotech company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders, priced an IPO upsized by 20% at the high end of the range and ended its first day of trading 48% above its offering price.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.